Aspirin and asthma

Chest

Volumn 118, Issue 5, 2000, Pages 1470-1476

  Babu, K S ^a   Salvi, S S ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Aspirin; Asthma; Cyclooxygenase; Desensitization; Leukotrienes

Indexed keywords

ACETYLSALICYLIC ACID; AZAPROPAZONE; BENZYDAMINE; CHLOROQUINE; CHOLINE MAGNESIUM TRISALICYLATE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; DICLOFENAC; INDOMETACIN; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; MELOXICAM; MONTELUKAST; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PEPTIDOLEUKOTRIENE; PIROXICAM; PRANLUKAST; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SALICYLAMIDE; SALICYLATE SODIUM; SULINDAC; TOLMETIN; UNINDEXED DRUG; ZAFIRLUKAST; ZILEUTON;

ANALGESIC ACTIVITY; ASTHMA; BRONCHOSPASM; CLINICAL FEATURE; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG UTILIZATION; HUMAN; HUMAN TISSUE; INFLAMMATION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RHINITIS; SINUSITIS; STROKE;

EID: 0033729001     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.5.1470     Document Type: Review

References (55)

1. Anaphylaxie et idiosyncrasie
2. Aspirin and concomitant idiosyncrasies in adult asthmatic patients
3. NSAID-induced bronchospasm: A common and serious problem; a report from MEDSAFE, the New Zealand medicines and medical devices safety authority
4. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study
5. Drug-induced pseudo-allergic syndrome as exemplified by acetyl salicylic acid intolerance
6. The potent and selective sulfidopeptide leukotriene antagonist, SK and F 104353, inhibits aspirin-induced asthma
7. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects
8. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge
9. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma
10. Molecular cloning of the gene for human leukotriene C4 synthase: Organization, nucleotide sequence, and chromosomal localization to 5q35
11. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma
12. Aspirin-induced asthma: Advances in pathogenesis and management
13. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription
14. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release
15. Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells
16. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma
17. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics
18. Too many COX (cyclo-oxygenase) spoil the broth: Aspirin-sensitive asthma and 5-lypoxygenase
19. Inflammatory cell populations in bronchial biopsies from aspirin- sensitive asthmatic subjects
20. The role of lung mononuclear cells in asthma, allergy and bronchial hyperresponsiveness
21. Expression of interleukin-5 and granulocyte-macrophage colony- stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways
22. Aspirin-induced asthma as a viral disease
23. Role of viral infections in the induction of adverse drug reactions
24. Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma
25. Intolerance to aspirin: Clinical studies and consideration of its pathogenesis
26. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs
27. Long-term prognosis of near-fatal asthma: A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near- fatal attack of asthma
28. Allergy to pyramidon (aminopyrine)
29. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis
30. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma
31. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects
32. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin
33. Relative safety of meloxicam in NSAID-intolerant patients
34. Hydrocortisone and airflow impairment in aspirin-induced asthma
35. Hydrocortisone sodium succinate does not cross-react with aspirin in aspirin-sensitive patients with asthma
36. Treatment of asthma with drugs modifying the leukotriene pathway
37. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin
38. Effectiveness of the 5-LO inhibitor zileuton during oral challenges in aspirin-sensitive asthmatics
39. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics
40. Montelucast (MK-0476) a CysLT1 receptor antagonist improves asthma control in aspirin-intolerant asthmatic patients
41. Leukotriene modifiers: New drugs, old and new reactions
42. Leukotriene modifiers and Churg-Strauss syndrome: Adverse effect or response to corticosteroid withdrawal?
43. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism
44. Aspirin desensitization in aspirin-sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period
45. Tolerance to aspirin in aspirin-sensitive asthmatics: Methods of inducing the tolerance state and its influence on the course of asthma and rhinosinusitis
46. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma
47. Long-term effects of aspirin desensitization-treatment for aspirin-sensitive rhinosinusitis-asthma
48. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes
49. Prevention of relapse in nasal polyposis
50. Adaptive desaktivierung bei analgetika-asthma syndrom: Methodik und phanomene der toleranzinduktion
51. Aspirin sensitivity: The role for aspirin challenge and desensitization in postmyocardial infarction patients
52. Inhibition of monocyte leukotriene B4 production after aspirin desensitization
53. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma
54. Aspirin-induced neutrophil chemotactic activity (NCA) in patients with aspirin-sensitive urticaria after desensitization to the drug
55. Asthma induced by aspirin and arachidonic acid metabolites: Role of leukotrienes